Alexion Pharmaceuticals, Inc.

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ALXN

Report date

6/30/2021

Quarter

2021 Q2

Filed

8/13/2021

Shares

1,002,319

Value ($000)

184,136

Weight

0.2%

2019 Q4 - 2021 Q2 (5 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q2	8/13/2021	184,136	0.2%	1,002,319	6/30/2021
2021 Q1	5/14/2021	12,630	0.0%	82,600	3/31/2021
2020 Q2	8/12/2020	1,179	0.0%	10,508	6/30/2020
2020 Q1	5/15/2020	28,029	0.1%	312,157	3/31/2020
2019 Q4	2/13/2020	12,383	0.0%	114,500	12/31/2019